Bacil Pharma Ltd — Important, 27-08-2025: Company Update
27-08-2025 | 03:02 pm
27-08-2025 | 03:02 pm
BACIL PHARMA LIMITED's board has approved key changes. The company appointed M/s Sarang Shivajirao Chavan & Associates as its new Statutory Auditor for the financial year 2025-2026. This firm is recognized for providing accurate financial insights, robust compliance, and strategic advisory. Additionally, the board approved the appointment of Mr. Vivek Mukesh Yadav as an Independent Director. Mr. Yadav brings sound knowledge in finance, accounts, and corporate management, with significant experience in financial planning and regulatory compliance. These appointments are set to strengthen the company's financial oversight and strategic direction.
No comments yet. Be the first to comment!
